NewAmsterdam Pharma @NewAmsPharma
NewAmsterdam Pharma is a late-stage clinical biopharmaceutical company focused on developing transformative therapies for cardiometabolic diseases. newamsterdampharma.com Joined August 2021-
Tweets308
-
Followers722
-
Following104
-
Likes78
A recent study in @ATHjournal notes that while we generally assume men have a more atherogenic lipid profile than women, that only holds true from ages 20 to 50. Before and after that, women typically have higher LDL-C and total cholesterol levels. bit.ly/3UlDYsT
Research from @TheFHFoundation found only 2% of U.S. patients at high risk of heart disease received a combination lipid-lowering therapy (LLT), and 80% of clinicians never prescribe combination LLTs. bit.ly/3Whf9Ru
The alarming rise in CVD deaths in recent years reinforces the importance of our work. Our R&D efforts are dedicated to combatting this trend by helping more patients reach and maintain their LDL-C goals. bit.ly/49UPoJz
Join us for a trip Back to the Future in this @Medscape CME that covers #CETP inhibition and how it may help reduce risk for patients with atherosclerotic cardiovascular disease (ASCVD). bit.ly/44hkudz
As a late-stage clinical biopharmaceutical company developing oral, non-statin medicines for people at risk of cardiovascular disease (CVD), our mission is to reverse the upward trend in CVD deaths. Meet the team taking on this formidable task. bit.ly/3WeDjMv
In this video, Christie Ballantyne, MD, discusses new data from the ROSE2 trial examining the potential synergistic effects of obicetrapib with ezetimibe in high-intensity statin users. hcplive.com/view/obicetrap… #Lipids
We’ve met the enrollment target in our pivotal Phase 3 PREVAIL CVOT and, driven by strong interest globally, expect to randomize more than 9,000 patients with a history of ASCVD. bit.ly/3TTqpAs
We're developing a selective CETP inhibitor, obicetrapib, observed in our ROSE2 study to cut LDL-C levels by a median 63.4% when taken with ezetimibe on top of high-intensity statins with or without food. Participants' muscle-related side effects were comparable to placebo.…
In our ROSE2 clinical trial, we observed significant decreases in both total (72.1%) and small (95.4%) LDL particle values among patients taking obicetrapib and ezetimibe on top of high-intensity statin therapy. This week at #ACC24, we’re presenting new data from the trial that…
A median 63.4% reduction in LDL-C was observed in patients receiving a combination of our potent CETP inhibitor, obicetrapib, and ezetimibe on top of high-intensity statins in our Phase 2 ROSE2 study. Our pivotal Phase 3 trial, TANDEM, will evaluate a fixed-dose combination of…
We're on our way to Atlanta for #ACC24, and we packed our data on the synergistic effect of obicetrapib and ezetimibe on circulating LDL particles. We look forward to collaborating with our peers on ways we can reduce the burden of cardiovascular disease. bit.ly/3U6TfPo
We’re excited to announce the appointment of Juliette Audet as our Chief Business Officer. While new to this management role, Juliette played a key role in the formation of NewAmsterdam Pharma and its early strategy as a member of our board of directors. bit.ly/4aFMXf4
According to NHANES data, high LDL-C is most prevalent among Mexican-American men and women, followed by Black men and women. We're developing a novel, oral, non-statin lipid-lowering therapy to help people reduce their LDL-C levels. bit.ly/3vb799p #MinorityHealth…
In multiple clinical trials, our novel, oral, non-statin lipid-lowering therapy, obicetrapib, has reduced LDL-C levels by 43-51% on top of high-intensity statins, with muscle-related pain side effects comparable to placebo, and no dietary restrictions or the need for dose…
While statins help many patients who need to reduce their risk of cardiovascular disease, they can also increase the risk of Type 2 #diabetes. In a comprehensive prespecified analysis, #CETP inhibition reduced diabetes risk genetically and clinically. bit.ly/3IASCqK…
We’ll be presenting a new analysis of data from our Phase 2 ROSE 2 clinical trial at #ACC24. The results demonstrate obicetrapib and ezetimibe’s impact on small dense LDL-C, a robust predictor of residual risk of future cardiovascular events. bit.ly/4ctcFoG
For now, there are no approved medicines to reduce Lp(a), but there are other ways to reduce your cardiovascular risk if you find you’re among the 1 in 5 people with high levels. @Drlipid shares several options to discuss with your doctor. #KnowLpa
We have multiple Phase 3 clinical trials underway to evaluate the efficacy of obicetrapib, our investigational non-statin lipid-lowering therapy. In two Phase 2 studies, we observed that obicetrapib reduced Lp(a) by 47-57% when taken with high-intensity statins. #KnowLpa
We have multiple Phase 3 clinical trials underway to evaluate the efficacy of obicetrapib, our investigational non-statin lipid-lowering therapy. In two Phase 2 studies, we observed that obicetrapib reduced Lp(a) by 47-57% when taken with high-intensity statins. #KnowLpa
Getting to #KnowLpa can help us reverse the alarming upward trend in deaths due to cardiovascular disease. Learn about this common genetic condition and find out if screening for Lp(a) is right for you.
Getting to #KnowLpa can help us reverse the alarming upward trend in deaths due to cardiovascular disease. Learn about this common genetic condition and find out if screening for Lp(a) is right for you.
High Lp(a) is a common genetic condition that causes early heart disease and stroke. As we join @TheFHFoundation in marking Lp(a) Awareness Day, get to #KnowLpa and understand what high levels can mean for your cardiovascular health. bit.ly/4a7gzlE
PREETHAM ANTON A @PreethamAnton
60 Followers 620 Following
Chuck E @ChuckE631670
0 Followers 3 Following
Dr Meral Kayikcioglu @MeralKayikcoglu
8K Followers 3K Following Prof of Cardiology, Director of Lipid & CV prevention clinic Ege University, EAS #SoMe Ambassador, Assoc Editor #ArchivesofTSC
Roberta Sanocki @RSanocki90393
71 Followers 5K Following
Roni Sinicki @sinic_ron
95 Followers 5K Following
KARE Rx Partners @KareRxPartners
57 Followers 303 Following At KARE RX Partners, we are dedicated to uniting independent #pharmacies across the USA.
John Rickert @JohnRickertMHIF
183 Followers 308 Following Dad | Husband | Virtual Event Lead | Hockey/Drumming/Fishing Enthusiast
Yun Grosso @grosso_gros
65 Followers 5K Following
John Besant-Jones @J_Besant_Jones
546 Followers 4K Following Special Situations Global Equity Analyst-Accounting red/green flags. Ex Institutional Buy/Sell side. Former Credit Suisse and ABN. Financial narrative checker.
Chantelle Elman @ChantelleE92824
74 Followers 5K Following
Memo Canli @Memo_Canli
3 Followers 10 Following Pioneering multi-omic precision medicine. Democratizing expertise.
Zoraida Mariacher @MariacZorai
50 Followers 5K Following
NexGen Research @NexgenResearch1
1 Followers 5 Following
Michael Morrison @M80709615
44 Followers 131 Following
Gabriele Schacter @GabrieleSc72931
87 Followers 5K Following
Stranamore @Dr_Wintermute
0 Followers 54 Following
Emmanuel Magutu @MagutuEmmanuel
0 Followers 2 Following
warrenstjohn @warrenstjohn
5K Followers 5K Following CEO, Patch. Author: Rammer Jammer Yellow Hammer, Outcasts United. NYT alum. Squeaky wheel for safer streets in NYC & sunshine in Central Park. RTR.
George @George87253995
71 Followers 282 Following interested in science, health, economy and covid-19
Hooshang Hosseinpour @HooshangHossei2
124 Followers 789 Following
Jim S @jimmysil
232 Followers 1K Following Spouse of @marciacreis123 I am a large North American woodpecker, almost crow-sized, inhabit deciduous forests in eastern North America, the Great Lakes.....
Malinda Holt @MalindaHolt68
85 Followers 420 Following God chose ME for the life I’m living!! I, will follow, while Jesus leads my heart. Enjoy the journey. I am! ❤️🙏🏻⚽️🚒
Robert Esgro @resgro
330 Followers 2K Following Husband, father to Luca & Marco, COO VindicoCME & HealioLive, golfer, GHS Baseball & UNC Asheville Baseball Alum
Ahmed el fouly @Ahmedelfouly83
0 Followers 30 Following
Madelynn Cronoble @cronoble10036
78 Followers 5K Following
Christian Nieroda @ChrisNieroda
113 Followers 155 Following Dad to Ethan & Claire, husband to Jeannine. @Pfizer, @Creighton, @Websteru, @Arsenal, U.S. National C License Coach
svb @svb69449401
10 Followers 109 Following
North Bluff Capital @bluff_capital
15K Followers 4K Following Market news. Tweets not recommendations, do your own research.
WP4KSP📡 @rubenNTX
251 Followers 2K Following Son of God. Living proof of perseverance. 🇩🇴 🇵🇷 🇺🇸 Hijo de Dios. Prueba viviente de perseverancia.
seyed saeed tamehri z.. @Tamehrysaeed
18 Followers 72 Following PHD student at UWA, working on FH and cardiovascular diseases under supervision of Gerald F Watts
Vish Sridharan @vishandchips1
103 Followers 304 Following MD, MBA | IM Attending by way of @MGHMedicine @mit_hst | biotech, drug development, healthcare investing
Molly Altenburg @molly_altenburg
226 Followers 789 Following Cardiology Fellow @UCCardsFellows. Just trying to interpret Chicago traffic reports
srstuewe @srstuewe
12 Followers 57 Following
Kevin Veltman @veltmke
7 Followers 247 Following
🐊ZK For Tre🐊 @ZKForTre
2K Followers 1K Following UF MD/PhD. PhD Neuroscience. Neurobio/Neuroimmuno/Metabolism/Stress Biology. Artist formerly known as Dr. Love/Pre-Med Guy. 🤟
[email protected] @irakleinzohoco1
675 Followers 3K Following
TerhoH @TerhoH
2 Followers 676 Following
Danielle Brennan @eemom91
43 Followers 493 Following Mom, professional, wife, coach, former athlete, overachiever
Dita Chin @dita_chin
127 Followers 2K Following Asian amateur crossdresser. Not looking 4 cash. don’t even try. be respectful. Conservative, don’t buy into gender and woke lunacy. treat me nice & kind please
Julian Engler @engle_juli
36 Followers 5K Following
C. Michael Gibson MD @CMichaelGibson
436K Followers 374K Following Non-Profit Founder/Leader | ❤️ Doc | Artist Scientist Educator | News Anchor https://t.co/7OIKCgMVAT | RT ≠ endorse | Disclaimer: https://t.co/bwmE2O3U5W
Hilly Paige Jr @hillypaige2
926 Followers 2K Following Very Proud Dad x2. Advocate for innovation and affordable access in healthcare. Avid hiker, skier, and scuba diver. Views expressed are my own. He/him
Dr Rob 🫀🩺 🇦�.. @drhungo
3K Followers 232 Following Primary Care Physician | Educator | Supervisor | ASCVD, 🫀Failure, Diabetes | Addicted to🏃♂️&🏌🏼♂️ Follows Jesus, loves family, tweets≠medical advice @RACGP
BiotechTV @BiotechTVHQ
6K Followers 34 Following News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
Scotty Kirkpatrick M... @drscottyk
2K Followers 764 Following Cardiology Fellow at the University of Arizona. Board Certified Internal Medicine Physician. Passion for Preventive Cardiology and Cardiometabolic Health.
Ann Marie Navar @AnnMarieNavar
4K Followers 259 Following Preventive cardiologist & CV researcher at UT Southwestern. Assoc Editor / DEI Deputy Editor at JAMA Cardiology. Tweets my own. she/hers
Kim Eagle @keaglemd
12K Followers 10K Following Editor, https://t.co/M0zlA4o2GO; Director-University of Michigan Frankel Cardiovascular Center; 'All opinions are my own'
Cardiac Trials @CardiacTrials
11K Followers 1K Following Simplified landmark cardiology trials app 📱 by cardiologist Justin Sharim MD. Mission: to spread evidence-based medicine worldwide 🌎
AHA Science @AHAScience
71K Followers 5K Following @American_Heart’s official account for meetings, science news, funding opportunities and membership. RTs/Follows not endorsements. Pump up your career, here.
Foundation of the NLA @foundationofnla
2K Followers 3K Following Dedicated to improving the welfare of patients and families affected by cholesterol and triglyceride problems.
Matthew Budoff MD @BudoffMd
5K Followers 44 Following Dr Budoff is a preventive cardiologist and Professor of Medicine at the David Geffen School of Medicine (UCLA) and principal investigator at Lundquist Institute
ASPC @ASPCardio
7K Followers 3K Following The ASPC is a group of physicians, researchers, and allied health professionals working in the field of preventive cardiology.
Erin D. Michos, M.D. @ErinMichos
31K Followers 10K Following Johns Hopkins, Cardiology. Co-Editor in Chief @AJPCardio. Director, #WomenHeartHealth. #Menopause #INOCA #CardioObstetrics #SCAD #cvPrev #lipids #echofirst.
Atherosclerosis @ATHjournal
6K Followers 4K Following Official Twitter account of #Atherosclerosis, the Journal of the European Atherosclerosis Society @society_eas 🫀
American Diabetes Ass.. @AmDiabetesAssn
143K Followers 1K Following We uplift people with #diabetes, break down barriers to care, & fund research. Explore the ADA’s Community Guidelines: https://t.co/u9o0jbt0Nb #WeFightDiabetes
Will Hubbard @wbhub
3K Followers 3K Following Building something new. Investing @adventure_fund, teaching @NorthwesternU.
Family Heart Foundati.. @FamilyHeartCMO
157 Followers 416 Following 🩺 Chief Medical Officer for the Family Heart Foundation, a patient-driven nonprofit focused on advocacy, research, and education of FH and high Lp(a).
Family Heart Foundati.. @TheFHFoundation
9K Followers 2K Following The Family Heart Foundation is a patient-driven nonprofit focused on advocacy, research and education of FH and elevated Lipoprotein(a). #KnowFH #KnowLpa
Journal of Clinical L.. @LipidJournal
2K Followers 3K Following The Journal of Clinical Lipidology is a leading peer-review journal covering a broad-array of topics within the clinical lipidology. Editor: John R. Guyton, MD.
FH Europe Foundation @fhpatienteurope
2K Followers 985 Following The European Network of Patient Organizations for inherited lipid conditions #FindFH #FindHoFH #FindLpa #FindFCS
European Lifestars Aw.. @lifestarsawards
77 Followers 102 Following The European Lifestars Awards (ELAs) celebrate the achievements of 130+ European life science leaders and the regions they represent.
Dr. Shashank Joshi @AskDrShashank
28K Followers 3K Following Chair IDF2019-22 Southeast Asia,https://t.co/Cp12WSmAXB, Past Dean Indian College of Physicians Views my own ,RTs not endorsements
Patrick M Looser MD @PLooserMD
1K Followers 1K Following Interventional Cardiologist at @TridentHealthPR. Trained @WeillCornell @MountSinaiNYC @GUMedicine #radialfirst #TAVR Not medical advice. Views my own.
European Society of C.. @ESCardioNews
27K Followers 3K Following @ESCardio Press Office account. Join us for the latest and hottest news in #cardiology #hearthealth #healthnews
Louise Kooij @kooij_louise
4 Followers 6 Following
JACC Journals @JACCJournals
105K Followers 1K Following Official account representing the ACC's #JACCJournals, one of the most widely read & most impactful CV journal programs in the world. @ACCinTouch #JACC
Rodrigo Alonso Karlez.. @KarleziAlonso
630 Followers 458 Following MD,PhD, FNLA;Internist; Lipidologist; Center Advanced Metabolic Medicine and Nutrition; President ATEROSCHILE. Fundación HF Spain. iberoamerican FH network. IAS
European Atherosclero.. @society_eas
5K Followers 712 Following Advancing and exchanging knowledge of the causes, natural history, treatments and prevention of atherosclerotic disease.
Dr Meral Kayikcioglu @MeralKayikcoglu
8K Followers 3K Following Prof of Cardiology, Director of Lipid & CV prevention clinic Ege University, EAS #SoMe Ambassador, Assoc Editor #ArchivesofTSC
Khurram Nasir @khurramn1
7K Followers 3K Following Husband, Father/ Preventive Cardiologist/Health Policy/ Social Justice & Health Equity/Big Data Applications
Prof Kausik Ray FMedS.. @ProfKausikRay
5K Followers 1K Following President European Atherosclerosis Society, Professor of Public Health, Imperial College London. Cardiologist focusing on preventing coronary artery disease
Roger Blumenthal @rblument1
8K Followers 5K Following Director of the Ciccarone Center for Prevention of Cardiovascular Disease. Husband, dad, son, science and sports enthusiast.
Vass Vassiliou @vass_vassiliou
9K Followers 4K Following Professor of Cardiology loving imaging, valves, prevention 🎶☕️ 🏃♂️ Treasurer & Exec Board EAPC, ESC - Editor @OxfordJournals🪑 #Comms & EIC NewsBeat @SCMRorg
Dariush Mozaffarian @Dmozaffarian
14K Followers 102 Following Friedman School of Nutrition Science & Policy, Tufts University. Cardiologist, nutrition scientist, public health advocate, happy husband + father
Amit Khera @dramitkhera
6K Followers 2K Following Professor and Director of Preventive Cardiology UT Southwestern Medical Center; Chair, AHA Committee on Scientific Sessions Programming; Past President ASPC
Lynne Braun, PhD @braun_lynne
2K Followers 2K Following Grandmother, Mother, Wife. Professor Emerita, Rush University; Passionate about preventing heart disease. Tweets are my own.
James V. Freeman @jfreeMD
1K Followers 394 Following Director, Cardiac Electrophysiology Laboratories at Yale New Haven Health, clinical researcher, husband, father
Salim Virani @virani_md
3K Followers 803 Following Vice Provost Research @ResearchAKU and a firm believer in the role of Civil Society. Preventive Cardiologist; Proud alumnus @AKUGlobal @BCMHeart @Texas_Heart
Karol Watson @kewatson
2K Followers 1K Following Passionate about #Cardiology, #WIC, and #healthequity. PD @UCLACVfellows
Anum Saeed @AnumSaeedMD
2K Followers 785 Following Preventive Cardiologist. Lipidologist. Focus: healthy heart & brain w/ aging. Passions: family, tennis, equality, +vity/gratitude! Tweets= not med. advice 🇵🇰
Alison L. Bailey, MD @a_l_bailey
5K Followers 4K Following Mom, cardiologist, KY Wildcat Fan. Editor-in-Chief #ACCEL Believes 🍎 a day will keep the 👩🏻⚕️away...Opinions my own
Dr. Martha Gulati ♥.. @DrMarthaGulati
60K Followers 9K Following Cardiologist, ❤️🩹Expert in Women & Heart Disease, Prevention, Author 'Saving Women's Hearts’- Heals 💔 President of ASPC #earlyinterventionalist @CedarsSinai
CVR Tomasz Guzik @CVR_TomaszGuzik
3K Followers 88 Following Cardiovascular Research Editor-in-Chief, Prof Tomasz J. Guzik. Managed by the editorial office. Tweets are our own. Retweet is not endorsement.
Silvia Castelletti @SilCastelletti
8K Followers 3K Following Cardiology - #EAPC_ESC #sports cardiology chair-elect - #genetic & #whyCMR- @escardio & @esc_journals SoMe Editor - #EJPC #EHJCR @Open_HeartBMJ Editorial Board
Henry Han @HanCardiomd
14K Followers 888 Following Cardiologist MBBS, MD, FACC, FESC | Physician-Sci & Researcher MPH | #HeartFailure👨🏼⚕️| #HFA & #EACVI Committee @escardio | Content Catalyst in @TCTMD
Eric Topol @EricTopol
694K Followers 589 Following physician-scientist, author, editor. Ground Truths: https://t.co/YhatcBT0hA
David J. Cohen, MD, M.. @djc795
16K Followers 684 Following Interventional and Structural Cardiologist. Dir. of Clinical and Outcomes Research, @crfheart. Director of Acad. Affairs, @StFrancis_LI. Die-hard Red Sox fan.
Dr Sam Raza, MD FACC .. @SamRRazaMD
12K Followers 2K Following Cardiologist. Parkland/UT Southwestern Trained. Imperial College Alum. Londoner. Passionate about #Cardiology #Prevention #CardiacImaging. Instagram: @drsamraza
Katherine Wilemon @KAWilemon
2K Followers 1K Following Founder & CEO @FamilyHeart Foundation. Citizen scientist living with Familial Hypercholesterolemia and elevated Lipoprotein(a). Truth, love, and nature matter.
Ritu Thamman MD @iamritu
29K Followers 3K Following Associate Professor #cardiologist #SoMe editor @CircOutcomes @JournalASEcho #BOD @ase360 @PittHealthSci @ColumbiaMed @NUFeinbergMed #echofirst #NewJersey girl👏👏👏 Congratulations to @mdavidsonmd, @JohnKastelein, and the entire @NewAmsPharma team. Very exciting! #LDL
We’ve met the enrollment target in our pivotal Phase 3 PREVAIL CVOT and, driven by strong interest globally, expect to randomize more than 9,000 patients with a history of ASCVD. bit.ly/3TTqpAs
In @NewAmsPharma's ROSE2 trial, we observed a median 63.4% reduction in LDL-C among participants taking a combination of our #CETP inhibitor, obicetrapib, and ezetimibe. Our Phase 3 TANDEM study will examine the two in a fixed-dose combination.
We are the Family Heart Foundation - a patient-centered #Research & #Advocacy organization dedicated to preventing early death and #HeartDisease by increasing the diagnosis, understanding and treatment of familial hypercholesterolemia and high lipoprotein(a). #KnowFH #KnowLpa
A4: Even though an estimated 1 in 5 have high Lp(a), fewer than 1% have ever had their Lp(a) tested. We have to do better! #KnowLpa
It's #LpaAwarenessDay! Let's raise our voices by sharing on social media or simply having a conversation. Together, we can save more families, more hearts. #KnowLpa Download from our toolkit & share today FamilyHeart.org/fh-awareness-d…
🚨Today is Lp(a) Awareness Day! Let's use our voices to shed light on the significance of Lp(a) testing. Early detection can be pivotal in preventing cardiovascular diseases. Join us in ensuring everyone knows why it's crucial to #KnowLpa @TheFHFoundation ow.ly/3CSf50R0ssI
I will be joining the prestigious faculty doing this one-hour Lp(a) Tweet-A-Thon - Will be introducing several new of my graphics - in rapid fire fashion @nationalipid @society_eas #KnowLpa @fhpatienteurope
Behind the scenes of our satellite media tour for Lp(a) Awareness! Thank you so much to @UTSWNews @dramitkhera and Family Heart Ambassador @purplevotaw for giving TV and radio interviews across the US to help everyone #KnowLpa! @KAWilemon
Do you know your Lp(a) level? In honor of Lp(a) Awareness Day on March 24, we are offering Lp(a) and LDL tests while supplies last! Get yours now: familyheart.org/ldl-and-lpa-sc…
sdLDL particles are more likely to get trapped in the arterial wall, leading to atherosclerosis. In @NewAmsPharma's ROSE2 clinical trial, patients receiving a combination of obicetrapib & ezetimibe achieved a >95% median reduction in small LDL-P levels. bit.ly/4coT5tt
All in Therapeutic Lipidology are holding their collective breaths. Obicetrapib is such a potentially exciting drug.
Our noteworthy progress and development in 2023 set us up to achieve significant milestones this year. By the end of Q1, we expect to have four active pivotal Phase 3 clinical trials, with two on track to report topline data in Q3 and Q4. Read more about our full-year 2023…
Translate 1 in 250 people who will have FH with >8 billion humans on the planet and recognize the true magnitude of the problem. @TheFHFoundation @nationallipid @society_eas @fhpatienteurope
Familial Hypercholesterolemia (FH) is a dominant genetic disorder, which means if you inherit the gene you will have the condition--even if you maintain a healthy diet and lifestyle. @American_Heart has information on the condition and current treatment options:
This was a #CME program I did for @PACEcme . #lipids #cvPrev. New therapies in the pipeline!
Dr. @ErinMichos shares The New Promise of CETPi, featuring an explanation of the mechanism, previous history, and the next generation of #CETP inhibitors--which starts with obicetrapib. Get up to speed in this 10-minute education segment from @PACEcme. bit.ly/4bpvgBs
A nice as well as succinct (short) review of the evolving CETP inhibition story, well done as usual, by @ErinMichos. Time for all to catch up and stay abreast of the topic. @nationallipid @society_eas
Dr. @ErinMichos shares The New Promise of CETPi, featuring an explanation of the mechanism, previous history, and the next generation of #CETP inhibitors--which starts with obicetrapib. Get up to speed in this 10-minute education segment from @PACEcme. bit.ly/4bpvgBs
@NewAmsPharma Promising. Excited for the upcoming clinical outcome studies
@NewAmsPharma Amazing and rapid as well as efficient journey by the team
@NewAmsPharma This is amazing news, really exited for obicetrapib’s phase 3
Trends for United States
You might like
